Xylem (XYL) Given a $78.00 Price Target at Canaccord Genuity

Canaccord Genuity set a $78.00 price objective on Xylem (NYSE:XYL) in a research note published on Tuesday. The firm currently has a hold rating on the industrial products company’s stock.

Several other analysts have also issued reports on XYL. Zacks Investment Research upgraded Xylem from a hold rating to a buy rating and set a $84.00 price objective for the company in a report on Saturday, April 7th. BMO Capital Markets reissued a buy rating and set a $86.00 target price on shares of Xylem in a research report on Friday, February 2nd. Seaport Global Securities reissued a buy rating and set a $83.00 target price on shares of Xylem in a research report on Friday, February 2nd. Cowen reissued a buy rating and set a $80.00 target price on shares of Xylem in a research report on Tuesday, March 6th. Finally, Oppenheimer increased their target price on shares of Xylem to $82.00 and gave the stock an outperform rating in a research report on Friday, February 2nd. Five equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The stock presently has a consensus rating of Buy and an average price target of $74.27.

How to Become a New Pot Stock Millionaire

Shares of NYSE:XYL opened at $75.49 on Tuesday. The company has a quick ratio of 1.41, a current ratio of 1.88 and a debt-to-equity ratio of 0.87. Xylem has a 1 year low of $49.71 and a 1 year high of $79.83. The firm has a market cap of $14,123.40, a P/E ratio of 31.45, a PEG ratio of 1.51 and a beta of 1.10.



Xylem (NYSE:XYL) last announced its quarterly earnings data on Thursday, February 1st. The industrial products company reported $0.76 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.76. Xylem had a return on equity of 17.95% and a net margin of 7.03%. The business had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.27 billion. During the same period last year, the company earned $0.66 earnings per share. Xylem’s quarterly revenue was up 16.6% compared to the same quarter last year. analysts anticipate that Xylem will post 2.92 earnings per share for the current year.

In other news, insider Tomas Brannemo sold 1,151 shares of the firm’s stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $76.41, for a total value of $87,947.91. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Curtis J. Crawford sold 7,948 shares of the firm’s stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $71.77, for a total value of $570,427.96. Following the completion of the sale, the director now directly owns 55,245 shares in the company, valued at $3,964,933.65. The disclosure for this sale can be found here. Insiders have sold 21,105 shares of company stock worth $1,540,907 over the last three months. Company insiders own 0.81% of the company’s stock.

Large investors have recently modified their holdings of the company. Greenleaf Trust grew its position in shares of Xylem by 97.4% in the fourth quarter. Greenleaf Trust now owns 1,490 shares of the industrial products company’s stock valued at $102,000 after purchasing an additional 735 shares during the last quarter. Hanson & Doremus Investment Management acquired a new stake in shares of Xylem in the fourth quarter valued at about $126,000. UMB Bank N A MO acquired a new stake in shares of Xylem in the fourth quarter valued at about $205,000. JOYN Advisors Inc. acquired a new stake in shares of Xylem in the fourth quarter valued at about $205,000. Finally, Close Asset Management Ltd acquired a new stake in shares of Xylem in the fourth quarter valued at about $205,000. 85.91% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION WARNING: This report was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this report on another site, it was stolen and reposted in violation of US and international trademark & copyright law. The legal version of this report can be accessed at https://stocknewstimes.com/2018/04/25/xylem-xyl-given-a-78-00-price-target-at-canaccord-genuity.html.

About Xylem

Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply